Continuous cardiac care, between every visit.
Molecula is a cardiology platform for clinics and cardiologists: remote monitoring, video consultations and the patient record in one place.
Four clinic visits a year leave 361 days in between.
The problem
Patients are alone between visits. Doctors are buried in data and paperwork.
Patients
| Problem | What Molecula does |
|---|---|
| Care pauses between visits: a cardiologist sees the patient every few months. | Monitoring continues at home, so the care team sees trends, not single readings. |
| Worsening heart failure, episodes of atrial fibrillation (AF) and rising blood pressure are often noticed late, sometimes first in the emergency department. | The care team is alerted when a reading crosses its threshold, and patients whose readings move away from their own baseline are flagged for review. |
| Routine follow-ups mean travel and waiting. | Follow-ups happen by video, with the doctor already looking at the patient’s latest readings. |
| Readings and reports are scattered across devices, PDFs and paper. | Readings arrive in one record. Patients add lab results and scans from their phone, and lab and imaging reports are digitised for the doctor to confirm. |
Your heart team, with you between appointments too.
Doctors
| Problem | What Molecula does |
|---|---|
| Notes take hours, often into the evening. | Notes are drafted from each video consultation for the doctor to review and sign. |
| Every patient looks the same until something goes wrong. | Patients who may need attention are flagged, and alerts are grouped by severity. |
| Risk scores are re-entered by hand. | Established risk scores are calculated from the record. |
| The record, video and monitoring live in separate tools. | Chart, monitoring, video consultations, messages and appointments sit in one product. |
See who needs you, before the next appointment.
How it works
From a reading at home to the doctor’s decision.
Collect
Readings from wearables and home devices, ECG recordings and questionnaire answers arrive in the patient’s record. Lab results and imaging reports the patient adds are digitised for the doctor to confirm.
Understand
Vital signs are checked against their ranges. The Cardio Score sums up how each patient is doing, and patients whose readings move away from their own baseline are flagged, with the findings behind each flag.
Act
The doctor reviews alerts by severity, consults by video with the latest readings in view, and signs a note Molecula drafts.
One record for the heart, alerts with their reasons, and scores with their inputs.
Unified information
Everything about the patient’s heart, in one place.
Vital signs and activity
Blood pressure, heart rate, weight, ECG, glucose, oxygen saturation and INR, with activity and sleep from the patient’s smartwatch, charted over time.
Devices
Smartwatches through Apple Health or Android, and home blood pressure monitors, scales and glucose monitors. Readings of one kind form a single series, whatever the device.
A cardiac chart
Cardiac status such as LVEF and NT-proBNP, interventions, the problem list, heart failure therapy against target doses, ECG recordings and the latest echo.
Cardio Score
A weekly 0–100 summary of each patient’s vital signs against their targets, activity, diet and body composition, with each domain behind it in view.
Smart alerts
Each alert shows what triggered it and how serious it is.
Graded readings
Every vital-sign reading is graded optimal, warning or critical, and each alert gives the reading, the patient’s target and the device it came from.
ECG checks
Each ECG recording shows rate, PR, QRS and QTc, and a prolonged PR or QTc, a rate outside the normal range or a non-sinus rhythm is flagged.
Patient stratification
Each flag and score shows what drives it.
Decompensation risk
Risk of heart failure decompensation, and of worsening AF or diabetes control, is flagged when the latest values move away from the patient’s 7-day baseline or condition-specific targets. Each flag lists the findings behind it.
Established risk scores
CHA₂DS₂-VASc, HAS-BLED and GRACE, calculated from the record, each showing the inputs or criteria it used.
Post-operative care and rehabilitation
The procedure is over. The care continues.
After PCI, CABG, TAVI or a device implant, the first weeks at home carry the highest risk of readmission. Molecula lets the care team follow recovery from home.
Each procedure on the chart
Each procedure is recorded with its details, alongside post-operative and cardiac rehab visits.
Monitoring at home
Blood pressure, heart rate, weight and oxygen saturation reach the care team from home devices, with an alert when something changes.
Activity and recovery
Steps, exercise minutes, walking speed, estimated VO₂ max and heart rate show how recovery is going.
Follow-up by video
Post-operative follow-ups by video, from home.
For doctors
Notes drafted from the consultation, for you to sign.
The Home screen: alerts by severity, plan updates waiting for approval, unread messages and today’s appointments.
In a time and motion study, doctors spent nearly two hours on the health record and desk work in the clinic day for every hour face to face with patients, and another one to two hours of their own time each night.
Sinsky C, et al. Ann Intern Med. 2016;165(11):753–760. 57 US doctors in four specialties, including cardiology.
Notes drafted for you
Each video consultation is transcribed as it happens, and a SOAP note is drafted from it, with your diagnoses and their ICD-10 codes in the assessment. You review it, add your own note and sign it; a signed note is locked.
Documents digitised
Lab reports, diagnostic reports and past notes from other services become structured data. Nothing enters the record until you confirm it.
You decide
As decision support, Molecula suggests treatment-plan changes based on European Society of Cardiology (ESC) and other guidelines, such as a dose change or a follow-up test. You approve or decline each one; a declined change leaves the plan as it is.
Why Molecula
Built for cardiology, with cardiologists
Designed with a panel of practising cardiologists and grounded in ESC and other international guidelines. Risk flags use condition-specific targets, and the Cardio Score is weighted by each patient’s documented conditions.
Standards-based data
Diagnoses carry ICD-10 codes and lab results are mapped to LOINC, so results from different laboratories trend as one series.
Developed in line with UK and EU MDR
Quality management, the software life cycle and risk management are set up in line with ISO 13485, IEC 62304 and ISO 14971.
Data protection by design
Designed around UK and EU GDPR. Clinician accounts support two-factor authentication, and each change to a record is logged with who made it and when.
Common questions
Where does Molecula use AI, and who decides?
To transcribe video consultations, draft SOAP notes and pre-visit briefs, digitise outside documents and suggest treatment-plan changes. All of it is decision support: the doctor confirms what is digitised, signs every note and approves or declines every change.
What does a patient need?
A phone and the link their clinic sends. It opens in the browser; from it they answer a health questionnaire, add lab results or scans and book their first visit. Their home devices then send readings to their record.
Is the Cardio Score a risk score?
No. It is a 0–100 summary of how a patient is doing across vital signs, activity, diet and body composition, for following one patient over time, not for comparing patients. For risk, Molecula calculates established scores and flags decompensation risk.